Peru Profile Updated with Additional Research Center Registration Requirements

October 31, 2024
Subscribe to these updates

The Peru profile in ClinRegs has been updated to include the following:

  • Requirement for the sponsor/contract research organization to ensure the research center is authorized in the specialty related to the proposed clinical trial (See Site/Investigator Selection)
  • Requirement for research centers to request an update of the validity of their Research Center Registration Certificates if they were issued prior to September 16, 2015 (See Site/Investigator Selection)

Please note that as of September 2024, the ClinRegs team has been unable to access the following Peruvian Clinical Trials Registry (Registro Peruano de Ensayos Clínicos (REPEC)) websites: https://ensayosclinicos-repec.ins.gob.pe and https://repec.ins.gob.pe. Direct links to sources contained on these sites may not work. The National Institute of Health (Instituto Nacional de Salud (INS)) is aware of this issue and is working to resolve it. The ClinRegs team will continue to monitor the situation.

Sources Added During this Update:

(Document) Communique No. 001-2024-DIIS/INS - Verification of Research Center Specialty Authorization in REPECv2 (PER-130 - Spanish) (English-PER-130 - Google Translation) (April 9, 2024)
Directorate of Health Research and Innovation, National Institute of Health

(Document) Communique No. 002-2024-DIIS/INS - Research Center Registration Certificate Validity Update Requirement (PER-131 - Spanish) (English-PER-131 - Google Translation) (June 10, 2024)
Directorate of Health Research and Innovation, National Institute of Health

Back to list